challenges for post-pci antiplatelet drugs
Published 12 years ago • 838 plays • Length 5:22Download video MP4
Download video MP3
Similar videos
-
4:13
post-stent antiplatelet therapy: longer wasn't better
-
2:52
shorten antiplatelet therapy after coronary stenting?
-
2:57
esc: cost, safety, and efficacy guide drug choice
-
3:32
percutaneous coronary intervention (pci) outcomes lag in women, minorities
-
6:33
augustus: dual surpasses triple therapy when afib patients have pci or acs
-
3:32
pci outcomes lag in women, minorities
-
6:45
dual anti-platelet therapy: how long after pci, cabg, acs?
-
4:25
statins before pci
-
12:01
apt: continuing dual antiplatelet therapy (dapt) post-pci
-
4:59
vorapaxar cut cv events but boosted bleeding
-
22:06
sglt-2 inhibitors and more practice changing data from esc 2019
-
0:59
antiplatelet therapy after coronary stenting
-
2:18
dapt: a concise summary.
-
3:48
ticagrelor delivers benefits, more bleeds in stable cad and diabetes
-
7:11
managing antiplatelet / antithrombotic use for high-bleeding risk patients - europcr 2023
-
19:10
acs / antithrombotics - s. wassmann
-
1:21:58
dapt challenges in complex clinical scenarios